Cargando…
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
INTRODUCTION: Minority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers of CYP2C19 variants has been reported in patients with either coronary artery disease (CAD) or acute coronary syndrome (ACS) after the perc...
Autores principales: | Hernandez-Suarez, Dagmar F, Melin, Kyle, Marin-Maldonado, Frances, Nunez, Hector J, Gonzalez, Ariel F, Gonzalez-Sepulveda, Lorena, Rivas-Tumanyan, Sona, Naik, Hetanshi, Ruaño, Gualberto, Scott, Stuart A, Duconge, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412606/ https://www.ncbi.nlm.nih.gov/pubmed/32764090 http://dx.doi.org/10.1136/bmjopen-2020-038936 |
Ejemplares similares
-
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016) -
2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018) -
Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics
por: Yang, Guang, et al.
Publicado: (2023) -
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
por: Duconge, Jorge, et al.
Publicado: (2021) -
Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)